Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BBIO	BRIDGEBIO PHARMA INC	$13.11B	N/A	-82.20%	-86.24%	-30.80%	-1.51	3.88	95.80%	-225.30%	-190.53%
TTRX	TURN THERAPEUTICS INC	$113.36M	N/A	N/A	N/A	N/A	7.53	1.43	N/A	N/A	N/A
SLGL	SOL-GEL TECHNOLOGIES LTD	$183.25M	N/A	N/A	N/A	N/A	0.33	5.15	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$156.21M	-53.60%	-25.40%	-35.53%	-123.40%	1.23	4.38	7.40%	-400.10%	-399.26%
NRSN	NEUROSENSE THERAPEUTICS LTD	$23.13M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
KZIA	KAZIA THERAPEUTICS LTD	$46.87M	N/A	-149.80%	280.88%	186.80%	-1.73	0.35	100.00%	-1,131.90%	-1,227.34%
RLMD	RELMADA THERAPEUTICS INC	$284.53M	-269.50%	-205.20%	-579.92%	-296.10%	0.57	2.86	N/A	N/A	N/A
NXTC	NEXTCURE INC	$29.75M	-132.90%	-98.60%	-202.71%	-149.10%	0.68	2.97	N/A	N/A	N/A
GRCE	GRACE THERAPEUTICS INC	$50.86M	-12.80%	-11.60%	-14.45%	758.10%	0.06	13.89	N/A	N/A	N/A
ABUS	ARBUTUS BIOPHARMA CORP	$738.52M	-50.20%	-37.60%	-45.57%	-57.70%	0.26	18.80	100.00%	-289.40%	-288.70%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$172.68M	-51.50%	-40.00%	-51.54%	-45.80%	0.29	7.76	100.00%	368.10%	368.64%
QTTB	Q32 BIO INC	$52.17M	N/A	-57.00%	-90.15%	-269.00%	-4.13	4.57	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$14.01B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$135.85M	N/A	N/A	N/A	N/A	0.22	5.48	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$1.55B	-42.90%	-38.80%	-46.69%	-45.00%	0.10	19.14	100.00%	-3,561.40%	-3,561.43%
HYFT	MINDWALK HOLDINGS CORP	$72.47M	-136.90%	-76.10%	-155.54%	-149.70%	0.47	4.19	58.50%	-146.10%	-159.30%
GLTO	GALECTO INC	$33.53M	-130.70%	-111.30%	-195.32%	-1,211.70%	0.34	3.73	N/A	N/A	N/A
GLUE	MONTE ROSA THERAPEUTICS INC	$1.27B	8.30%	5.10%	5.51%	9.80%	0.87	6.54	100.00%	11.50%	12.09%
CANF	CAN-FITE BIOPHARMA LTD	$2.75M	-264.10%	-129.00%	-157.13%	1,180.30%	0.85	3.60	100.00%	-1,571.30%	-1,571.25%
SLS	SELLAS LIFE SCIENCES GROUP INC	$531.31M	-95.20%	-75.10%	-56.85%	1,520.90%	0.13	8.28	N/A	N/A	N/A
NVO	NOVO NORDISK A S	$212.71B	61.10%	20.20%	39.89%	51.50%	1.80	0.80	81.00%	33.10%	42.24%
INSM	INSMED INC	$31.96B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
CAMP	CAMP4 THERAPEUTICS CORP	$180.02M	-100.10%	-76.60%	-68.03%	-490.20%	0.47	9.83	100.00%	-1,404.50%	-1,404.47%
ACOG	ALPHA COGNITION INC	$110.88M	-52.60%	-40.80%	-50.11%	-1,606.00%	0.37	6.69	73.10%	-262.20%	-266.30%
HRTX	HERON THERAPEUTICS INC	$231.04M	N/A	-5.70%	-6.97%	-4.50%	15.73	2.56	73.90%	-8.80%	-7.15%
HYPD	HYPERION DEFI INC	$33.52M	-123.80%	-71.30%	-30.02%	-78.70%	0.17	2.25	-798.10%	-7,643.90%	-6,846.13%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$39.32M	-316.10%	-176.10%	-1,881.63%	435.00%	3.23	1.21	N/A	N/A	N/A
AKTS	AKTIS ONCOLOGY INC	N/A	N/A	N/A	N/A	N/A	-0.59	9.27	N/A	N/A	N/A
GRDX	GRIDAI TECHNOLOGIES CORP	$9.78M	-888.30%	-16.40%	-4.86%	-9.10%	2.03	2.62	N/A	N/A	N/A
TCRX	TSCAN THERAPEUTICS INC	$58.45M	-73.90%	-45.10%	-59.97%	-67.10%	0.82	6.44	100.00%	-1,693.00%	-1,659.11%
IVVD	INVIVYD INC	$370.67M	-93.00%	-51.90%	-63.24%	-758.30%	0.50	2.47	93.30%	-119.60%	-119.63%
SEER	SEER INC	$99.86M	-26.50%	-23.60%	-26.94%	-26.10%	0.14	14.25	50.70%	-484.50%	-482.85%
LXEO	LEXEO THERAPEUTICS INC	$522.59M	-90.50%	-70.90%	-82.85%	-112.40%	0.19	7.40	N/A	N/A	N/A
PLYX	POLARYX THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	0.13	8.77	N/A	N/A	N/A
PASG	PASSAGE BIO INC	$30.23M	-102.10%	-53.00%	-87.19%	-120.00%	1.38	2.51	N/A	N/A	N/A
XLO	XILIO THERAPEUTICS INC	$28.40M	-857.90%	-52.90%	-75.67%	265.00%	-17.52	2.20	100.00%	-183.90%	-183.90%
IBIO	IBIO INC	$54.42M	-83.60%	-62.80%	-34.28%	-171.80%	0.15	8.40	100.00%	-4,021.60%	-3,983.40%
PBM	PSYENCE BIOMEDICAL LTD	$937.52k	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$131.50M	-56.60%	-40.20%	-49.47%	-40.10%	0.47	7.87	100.00%	-2,187.10%	-2,187.11%
LEGN	LEGEND BIOTECH CORP	$3.16B	-23.40%	-14.30%	-15.74%	-27.80%	0.69	2.87	60.60%	-26.40%	-22.16%
PVLA	PALVELLA THERAPEUTICS INC	$972.96M	-68.50%	-45.50%	-49.43%	433.60%	0.73	6.49	100.00%	66,162.30%	52,807.55%
IVA	INVENTIVA SA	$562.49M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%
KYNB	KYNTRA BIO INC	$33.25M	-126.40%	124.20%	213.12%	161.40%	-7.02	3.71	82.70%	-182.60%	-182.34%
SNSE	SENSEI BIOTHERAPEUTICS INC	$11.18M	-80.00%	-67.50%	-104.06%	-104.00%	0.20	5.81	N/A	N/A	N/A
XNCR	XENCOR INC	$829.08M	-20.40%	-14.50%	-12.25%	-9.80%	0.39	6.00	100.00%	-87.10%	-63.85%
PLRZ	POLYRIZON LTD	$12.59M	-12.40%	-11.70%	-18.72%	-3,440.00%	0.02	44.04	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$704.78M	-49.00%	-44.70%	-36.20%	-139.20%	0.13	9.01	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-253.40%	-147.00%	-61.57%	750.70%	0.25	4.76	N/A	N/A	N/A
CVM	CEL SCI CORP	$42.04M	-240.40%	-105.90%	-107.54%	-115.00%	0.76	2.26	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.16B	-67.70%	-47.50%	-54.43%	-51.00%	0.49	10.57	100.00%	-1,618.00%	-1,521.18%
ALGS	ALIGOS THERAPEUTICS INC	$45.04M	-132.40%	-74.30%	-84.18%	-123.30%	0.53	4.70	100.00%	-3,267.60%	-2,792.71%
MDWD	MEDIWOUND LTD	$228.09M	-62.10%	-27.10%	-24.94%	-55.90%	0.88	2.65	18.50%	-98.40%	-81.22%
CRBU	CARIBOU BIOSCIENCES INC	$146.74M	-80.80%	-62.70%	-94.14%	-69.20%	0.38	5.54	100.00%	-1,690.40%	-1,690.54%
MDGL	MADRIGAL PHARMACEUTICALS INC	$10.85B	-41.50%	-26.20%	-27.97%	-32.00%	1.18	3.44	95.30%	-39.00%	-36.67%
OKYO	OKYO PHARMA LTD	$73.83M	N/A	-123.50%	183.14%	79.90%	-2.36	0.58	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$18.48B	-18.30%	-15.60%	-14.29%	-20.80%	0.06	30.66	91.20%	-6,079.90%	-5,446.60%
PEPG	PEPGEN INC	$307.99M	-84.10%	-65.60%	-53.08%	-125.70%	0.17	13.15	N/A	N/A	N/A
EVMN	EVOMMUNE INC	$545.68M	N/A	N/A	N/A	N/A	-0.06	7.87	N/A	N/A	N/A
COYA	COYA THERAPEUTICS INC	$101.27M	-57.40%	-49.70%	-67.50%	-49,060.60%	0.17	8.73	100.00%	-462.30%	-480.32%
URGN	UROGEN PHARMA LTD	$999.37M	N/A	-71.00%	-102.36%	-74.20%	-2.60	3.99	88.00%	-170.60%	-151.45%
PRTA	PROTHENA CORP PUBLIC LTD CO	$479.63M	-72.70%	-62.50%	-79.27%	-3,639.10%	0.20	6.61	100.00%	-2,379.60%	-2,025.72%
PTHS	PELTHOS THERAPEUTICS INC	$70.39M	-210.30%	-72.80%	-21.88%	-431.20%	1.17	2.01	68.70%	-318.40%	-300.30%
LBRX	LB PHARMACEUTICALS INC	$602.62M	N/A	N/A	N/A	N/A	0.03	47.60	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.85B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
ALMS	ALUMIS INC	$2.73B	-75.50%	-57.60%	-60.04%	-105.60%	0.27	6.01	100.00%	-1,108.20%	-1,146.94%
GLSI	GREENWICH LIFESCIENCES INC	$401.78M	-1,042.80%	-565.50%	-891.35%	1,235.40%	0.74	2.35	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$1.53B	-25.80%	-20.20%	-20.82%	-28.70%	0.12	8.29	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$27.51M	-92.40%	-75.70%	-77.48%	3,325.10%	0.18	6.50	100.00%	-304.50%	-303.47%
ADCT	ADC THERAPEUTICS SA	$496.75M	N/A	-55.40%	-50.64%	-97.80%	-2.22	4.63	92.70%	-222.00%	-153.31%
GERN	GERON CORP	$976.68M	-30.30%	-14.00%	-9.57%	-6.90%	1.28	5.96	97.70%	-43.60%	-25.04%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.38B	-436.00%	-43.70%	-67.82%	-38.30%	543.90	1.89	84.70%	-91.90%	-91.46%
TLSA	TIZIANA LIFE SCIENCES LTD	$151.59M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$753.14M	N/A	N/A	N/A	N/A	19.00	7.22	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.47B	-31.20%	-29.30%	-24.11%	-50.10%	0.05	21.93	N/A	N/A	N/A
ATON	ALPHATON CAPITAL CORP	$3.08M	-271.20%	-89.50%	-164.61%	-332.40%	2.26	0.88	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.89B	-29.10%	-26.90%	-30.36%	-211.70%	0.08	12.57	100.00%	-627.30%	-627.28%
JANX	JANUX THERAPEUTICS INC	$786.13M	-10.20%	-9.80%	-10.22%	-11.40%	0.05	35.86	100.00%	-1,019.00%	-1,018.95%
ZLAB	ZAI LAB LTD	$1.99B	-25.80%	-17.70%	-25.28%	-96.60%	0.53	2.87	61.30%	-46.80%	-45.75%
ALT	ALTIMMUNE INC	$507.72M	-54.80%	-47.60%	-40.73%	-92.80%	0.18	17.18	100.00%	-559,433.30%	-558,900.00%
OCS	OCULIS HOLDING AG	$1.59B	-81.70%	-61.80%	-77.18%	-150.90%	0.29	4.47	100.00%	-36,145.10%	-35,938.25%
THAR	THARIMMUNE INC	$145.09M	-588.40%	-264.40%	-167.25%	641.10%	0.25	4.99	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$204.61M	-48.90%	-37.40%	-49.86%	-45.70%	0.31	6.19	100.00%	-404.80%	-402.55%
TPST	TEMPEST THERAPEUTICS INC	$10.66M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
NKTX	NKARTA INC	$143.48M	-27.70%	-22.20%	-25.13%	-21.80%	0.26	15.24	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$93.57M	-150.10%	-95.90%	-76.14%	728.50%	0.19	6.45	N/A	N/A	N/A
NBY	NOVABAY PHARMACEUTICALS INC	$95.77M	113.90%	54.80%	159.05%	529.50%	1.67	2.00	54.60%	114.60%	114.59%
PCSA	PROCESSA PHARMACEUTICALS INC	$5.39M	-301.40%	-217.30%	-221.71%	250,955.20%	0.30	3.76	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$256.40M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
PTGX	PROTAGONIST THERAPEUTICS INC	$5.28B	6.90%	6.30%	7.32%	8.50%	0.09	13.05	100.00%	21.90%	22.98%
GALT	GALECTIN THERAPEUTICS INC	$180.52M	N/A	-269.90%	24.43%	-70.60%	-1.09	0.09	N/A	N/A	N/A
XCUR	EXICURE INC	$25.69M	-108.80%	-52.90%	-73.84%	-897.50%	1.20	1.96	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.75B	-24.90%	-24.00%	-20.41%	-34.80%	0.03	32.95	N/A	N/A	N/A
RANI	RANI THERAPEUTICS HOLDINGS INC	$148.24M	N/A	-129.00%	273.69%	-132.60%	-2.81	0.26	100.00%	-2,359.60%	-2,053.83%
NUVB	NUVATION BIO INC	$1.95B	-55.00%	-38.10%	-39.44%	-42.00%	0.85	8.48	54.30%	-813.10%	-786.53%
MBX	MBX BIOSCIENCES INC	$1.69B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$719.07M	-295.60%	-135.20%	-204.90%	-4,670.60%	1.09	1.80	100.00%	-2,273.90%	-2,271.65%
KPTI	KARYOPHARM THERAPEUTICS INC	$106.74M	N/A	-101.10%	-883.59%	-45.00%	-1.36	1.03	95.90%	-87.40%	-56.26%
ANRO	ALTO NEUROSCIENCE INC	$472.83M	-47.40%	-38.10%	-43.51%	-245.30%	0.32	15.42	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$1.61B	-33.40%	-22.70%	-21.45%	-27.40%	0.06	25.61	N/A	N/A	N/A
OCGN	OCUGEN INC	$415.39M	-491.20%	-99.20%	-163.12%	-157.50%	15.30	1.85	100.00%	-1,192.20%	-1,131.02%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #1 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 15, which is -9 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 5 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -26.92% over the past year, overperforming other biotech stocks by 4 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $21.86, an upside of 242.59% from Biocryst Pharmaceuticals's current stock price of $6.38.

Biocryst Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Biocryst Pharmaceuticals, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -8 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 37.84% over the past year, overperforming other biotech stocks by 69 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $213.27, an upside of 28.87% from Jazz Pharmaceuticals's current stock price of $165.50.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: B, Safety: C, Financials: C, and AI: B.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 33, which is 9 points higher than the biotech industry average of 24.

PHAR passed 10 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 81.4% over the past year, overperforming other biotech stocks by 112 percentage points.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 26.41%, which is 21 percentage points higher than the biotech industry average of 5.56%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.33%, which is 2 percentage points higher than the biotech industry average of 5.56%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.97%, which is -4 percentage points lower than the biotech industry average of 5.56%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and down -0.36% over the last week. Roivant Sciences was the among the top gainers in the biotechnology industry, gaining 22.14% yesterday.

Roivant Sciences shares are trading higher after the company reported better-than-expected Q3 sales results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the biotech industry average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -3.89% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Innoviva's stock has gained 19.39% in the past year. It has overperformed other stocks in the biotech industry by 50 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 44.62% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

64.15% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.9% over the next year.

3.35% of biotech stocks have a Zen Rating of A (Strong Buy), 6.5% of biotech stocks are rated B (Buy), 41.93% are rated C (Hold), 37.53% are rated D (Sell), and 10.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 234.95x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.